Introduction: Hepatitis B vaccination protects newborns from contracting a virus that may lead to chronic infection, liver failure or death. Ensuring administration of the vaccine within 12 hours of birth or prior to discharge minimizes the newborns’ opportunity to contract the virus. In the US, approximately 70% of infants receive the birth dose of Hepatitis B vaccine (i.e., within 3 days of birth). Phase 1 of our quality improvement project demonstrated significant improvement in Hepatitis B birth dose vaccination rates (from 52 to 70%) and timely vaccination rates (from 19 to 40%). Interventions implemented were hospital staff and parent education, along with revision of the hospital birth dose policy. The second (ongoing) phase aims to reach the Healthy 2020 goal (>85%) vaccination rate. Objectives: We aim to increase the hepatitis B birth dose vaccination rate to >85% over three years. We also aim to increase the timely vaccination rate in...
Skip Nav Destination
Article navigation
Meeting Report|
July 01 2020
2020 Hepatitis B birth dose and timely vaccination goals: Are we there yet? Available to Purchase
Katherine Pelts, MD;
Katherine Pelts, MD
(1) Richmond University Medical Center, Brooklyn, NY
Search for other works by this author on:
Teresa Lemma, MD
Teresa Lemma, MD
(2) Richmond University Medical Center, Staten Island, NY
Search for other works by this author on:
Pediatrics (2020) 146 (1_MeetingAbstract): 554–556.
Citation
Katherine Pelts, Teresa Lemma; 2020 Hepatitis B birth dose and timely vaccination goals: Are we there yet?. Pediatrics July 2020; 146 (1_MeetingAbstract): 554–556. 10.1542/peds.146.1MA6.554
Download citation file:
Sign in
Don't already have an account? Register
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Pay-Per-View Access
$35.00
Comments